FROM BIO CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,245 KRW | +1.58% |
|
+1.81% | -26.87% |
| 2023 | From Bio Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2021 | From Bio Co.,Ltd has completed an IPO in the amount of KRW 43.2 billion. | CI |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 154,290 | 118,477 | 86,912 |
| Enterprise Value (EV) 1 | 110,678 | 92,154 | 99,230 |
| P/E ratio | 11.8 x | 36.6 x | -7.85 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.14 x | 1.19 x | 1.3 x |
| EV / Revenue | 0.82 x | 0.93 x | 1.49 x |
| EV / EBITDA | 8.86 x | 45.2 x | -7.2 x |
| EV / FCF | - | -5,180,899 x | -3,094,661 x |
| FCF Yield | - | -0% | -0% |
| Price to Book | 1.83 x | 1.35 x | 1.13 x |
| Nbr of stocks (in thousands) | 28,310 | 28,310 | 28,310 |
| Reference price 2 | 5,450 | 4,185 | 3,070 |
| Announcement Date | 23-03-15 | 23-03-15 | 24-03-20 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net sales 1 | 135,103 | 99,330 | 66,724 |
| EBITDA 1 | 12,496 | 2,039 | -13,775 |
| EBIT 1 | 11,424 | 897 | -15,420 |
| Operating Margin | 8.46% | 0.9% | -23.11% |
| Earnings before Tax (EBT) 1 | 11,638 | 1,512 | -15,740 |
| Net income 1 | 11,282 | 3,241 | -11,076 |
| Net margin | 8.35% | 3.26% | -16.6% |
| EPS 2 | 460.6 | 114.5 | -391.2 |
| Free Cash Flow | - | -17,787 | -32,065 |
| FCF margin | - | -17.91% | -48.06% |
| FCF Conversion (EBITDA) | - | - | - |
| FCF Conversion (Net income) | - | - | - |
| Dividend per Share | - | - | - |
| Announcement Date | 23-03-15 | 23-03-15 | 24-03-20 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Net Debt 1 | - | - | 12,318 |
| Net Cash position 1 | 43,611 | 26,324 | - |
| Leverage (Debt/EBITDA) | - | - | -0.8942 x |
| Free Cash Flow | - | -17,787 | -32,065 |
| ROE (net income / shareholders' equity) | - | 1.54% | -14.3% |
| ROA (Net income/ Total Assets) | - | 0.59% | -10.1% |
| Assets 1 | - | 549,800 | 109,861 |
| Book Value Per Share 2 | 2,982 | 3,107 | 2,707 |
| Cash Flow per Share 2 | 287.0 | 63.90 | 227.0 |
| Capex 1 | 8,781 | 13,589 | 16,656 |
| Capex / Sales | 6.5% | 13.68% | 24.96% |
| Announcement Date | 23-03-15 | 23-03-15 | 24-03-20 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -26.87% | 46.41M | |
| +16.80% | 8.43B | |
| +15.02% | 6.82B | |
| -4.77% | 3.77B | |
| -6.75% | 3.74B | |
| +4.41% | 1.44B | |
| -30.34% | 1.06B | |
| +20.28% | 1.04B | |
| -12.85% | 890M | |
| -15.63% | 812M |
- Stock Market
- Equities
- A377220 Stock
- Financials From Bio Co.,Ltd
